NETs Formation in Patients With Recurrent Pyogenic Infections (NETS)
NCT01112592 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2013-02-27
Summary
We aim to study if pathological NETs formation could be the underlying pathology among patients with recurrent infections and a normal screening of the immune system.
Conditions
- Pyogenic Infections
Sponsors & Collaborators
-
Max Planck Institute for Infection Biology
collaborator OTHER -
Meir Medical Center
lead OTHER
Principal Investigators
-
Baruch Wolach, MD · Meir Medical Center
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-05-31
- Primary Completion
- 2013-05-31
- Completion
- 2013-12-31
Countries
- Israel
Study Locations
More Related Trials
-
Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis)
NCT01862068 ·Status: COMPLETED
-
Non Randomized Comparative Study With Control
NCT03294824 ·Status: UNKNOWN
-
Feasibility Study of Platelet Activation and Inflammatory Response of Platelets in Hematopoietic Stem Cell Allograft Patients Post-transplant: Spontaneously and After Stimulation by an CMV Antigen
NCT03009708 ·Status: COMPLETED ·Phase: NA
-
Granulocyte Transfusions in Hematological Patients With Febrile Neutropenia
NCT02544230 ·Status: COMPLETED
-
Maintenance of ANCA Vasculitis Remission by Intermittent Rituximab Dosing
NCT02749292 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of Anti-neutrophil Cytoplasm Antibodies Test
NCT04719715 ·Status: UNKNOWN
-
Establishment of an Early Warning Screening System for Hemophagocytic Lymphohistiocytosis a Multi-center, Prospective Study
NCT06614998 ·Status: RECRUITING
-
The Effect of Monocyte Values Accompanied by Lymphopenia on the Prognosis of Patients Diagnosed With COVID-19
NCT06968156 ·Status: COMPLETED
-
INS, B Cells and Microbiota
NCT04924712 ·Status: RECRUITING
-
Inflammatory Proteins in Familial Mediterranean Fever During Attack and Remission
NCT00323440 ·Status: WITHDRAWN
-
Intravenous Immunoglobulin After Relapse in Vasculitis
NCT00307658 ·Status: TERMINATED ·Phase: PHASE3
-
CellCept in p-ANCA Vasculitis
NCT00405860 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis
NCT04871191 ·Status: RECRUITING ·Phase: PHASE3
-
Immunoadsorption Study Mainz in Adults With Post-COVID Syndrome
NCT05841498 ·Status: COMPLETED ·Phase: NA
-
Role of the Nuclear Pore Component RANBP2 in Inflammatory Responses to Viral Infections
NCT06731790 ·Status: COMPLETED ·Phase: NA
-
Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy
NCT05894512 ·Status: COMPLETED
-
Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
NCT00246857 ·Status: RECRUITING
-
Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis
NCT00059748 ·Status: RECRUITING
-
Interleukin-8 Level in Packed Red Blood Cells
NCT06530160 ·Status: NOT_YET_RECRUITING
-
Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis
NCT02169219 ·Status: COMPLETED ·Phase: PHASE4
-
Plasma Exchange in Covid-19 Patients With Anti-interferon Autoantibodies
NCT05182515 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)
NCT06226662 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
MoMa Signature During Granulomatosis
NCT05916638 ·Status: RECRUITING
-
Interferon-pegyle α2a Efficiency and Tolerance in Myelofibrosis
NCT02910258 ·Status: COMPLETED
-
Tailoring Maintenance Therapy to Cluster of Differentiation 5 Positive (CD5+) Regulatory B Cell Recovery in ANCA Vasculitis
NCT03906227 ·Status: TERMINATED ·Phase: NA